11 completed, 4 unknown, 2 terminated, 1 not yet recruiting. 20 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 20 | Completed 11, Unknown 4, Terminated 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
| Phase 2 | 6 | Completed 4, Terminated 2 |
Follow Wound Healing: new trials by email Literature Review of Wound Healing trials Research Report on Wound Healing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of LUT017 Gel to Improve Healing of Skin Wounds After Removal of Benign Lesions in Healthy Adults LUT017,Topical BRAF inhibitor - Wound Healing, Acute Skin Wounds | Phase 1 | Not yet recruiting | Antoni Ribas | 9 | 2026-04-01 | 2026-05-29 |
| Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds Timolol Maleate Solution, Standard of Care - Wound Healing, Mohs Micrographic Surgery | Phase 1 | Recruiting | Icahn School of Medicine at Mount Sinai | 102 | 2025-01-03 | 2026-10-09 |
| Effect of Phenytoin Cream on Wound Healing After Anal Fissure Surgery. phenytoin cream, no phenytoin cream - Anal Fissure Chronic, Anal Fissure | Phase 1 | Completed | Mansoura University | 50 | 2022-01-01 | 2024-10-09 |
| Clinical Comparison of Topical Application of Alvogyl Versus Hyaluronic-Acid Gel in Management of Pain And Palatal Wound Healing Alvogyl - Wound Healing | Phase 1 | Unknown | Cairo University | 16 | 2021-12-01 | 2022-04-19 |
| Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants TolaSure Topical Gel - Wound Healing | Phase 1 | Completed | BioMendics, LLC | 22 | 2018-07-16 | 2019-01-30 |
| Controlled Comparison of a Traditional Dressing Versus a Biologic Dressing Composed of Fetal Fibroblasts and Keratinocytes in Association With a Collagen Matrix on Skin Donor Sites biological dressing, Paraffin gauze dressing - Split Thickness Skin Graft, Wound Healing | Phase 1 / Phase 2 | Terminated | Nantes University Hospital | 28 | 2018-05-16 | 2024-08-12 |
| Wound Treatment With 3% Sodium Pentaborate Pentahydrate 3% Sodium Pentaborate Pentahydrate, Placebo - Wound Healing | Phase 1 | Unknown | SB Istanbul Education and Research Hospital | 20 | 2014-09-01 | 2019-01-15 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 GSK1278863, Placebo - Wound Healing | Phase 1 | Completed | GlaxoSmithKline | 65 | 2013-06-17 | 2019-08-19 |
| The Effect of OASIS Ultra on Critical Sized Wound Healing OASIS Ultra, Wound VAC Standard Therapy - Traumatic Wound, Infective Wound | Phase 1 | Completed | Massachusetts General Hospital | 7 | 2013-05-01 | 2019-10-30 |
| Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy Phenytoin paste, Placebo - Wound Healing, Pain | Phase 1 | Unknown | Shahid Beheshti University of Medical Sciences | 40 | 2012-10-01 | 2012-10-02 |
| Wound Healing of Incisional Wounds for Bilateral Hernia Repair Dermabond, Hydrogen Peroxide Oxygen producing gel - Wound Healing | Phase 1 | Withdrawn | Wake Forest University | 2009-10-01 | 2017-11-06 | |
| Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds Procellera (Bioelectric Wound Dressing), Opsite (Transparent Adhesive Dressing) - Burns, Wound Healing | Phase 1 / Phase 2 | Completed | Vomaris Innovations | 17 | 2009-09-01 | 2010-12-10 |
| A Study Evaluating Nexagon™ in the Treatment of Skin Wounds. Nexagon™ or Nexagon™ vehicle - Wound Healing | Phase 1 | Completed | OcuNexus Therapeutics, Inc. | 43 | 2008-09-01 | 2009-04-27 |
| Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model Stem cell therapy - Chronic Wounds, Pressure Sores | Phase 1 | Unknown | University Hospital, Basel, Switzerland | 2007-01-01 | 2007-09-26 | |
| Topical Hydromorphone for Wound Healing hydromorphone - Wound Healing | Phase 1 / Phase 2 | Terminated | Hordinsky, Maria K., MD | 50 | 2003-10-01 | 2010-03-01 |
| Safety and Efficacy Study of Avotermin (Juvista) in Female Subjects Avotermin, Placebo - Cicatrix, Wound Healing | Phase 1 / Phase 2 | Completed | Renovo | 35 | 2003-04-01 | 2009-09-25 |
| Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects Intradermal avotermin, Placebo (vehicle), Placebo - Cicatrix, Wound Healing | Phase 1 / Phase 2 | Completed | Renovo | 20 | 2002-09-01 | 2009-09-16 |
| Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista) Avotermin, Placebo - Cicatrix, Wound Healing | Phase 1 / Phase 2 | Completed | Renovo | 43 | 2002-02-01 | 2009-09-16 |
| Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista) Avotermin, Placebo (vehicle) - Cicatrix, Wound Healing | Phase 1 | Completed | Renovo | 55 | 2001-05-01 | 2009-09-16 |
| Effects of Topical SLPI on Skin Wounds SLPI (Secretory Leukocyte Protease Inhibitor) - Healthy, Wound Healing | Phase 1 | Completed | National Institute of Dental and Craniofacial Research (NIDCR) | 60 | 2000-04-01 | 2008-03-04 |
Cicatrix (4) · Wounds and Injuries (3) · Burns (1) · Coitus (1) · Diabetic Foot (1) · Fissure in Ano (1) · Inflammation (1) · Ischemia (1) · Pain (1) · Pressure Ulcer (1)
Pathological Conditions, Signs and Symptoms (7) · Pathologic Processes (6) · Fibrosis (4) · Skin Diseases (2) · Skin Ulcer (2) · Skin and Connective Tissue Diseases (2) · Anus Diseases (1) · Behavior (1) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Diabetic Neuropathies (1) · Digestive System Diseases (1) · Endocrine System Diseases (1)
TGFB3 protein, human (4) · Ltbp3 protein, zebrafish (2) · Transforming Growth Factor beta3 (2) · Biological Dressings (1) · Control Groups (1) · GSK1278863 (1) · Hyaluronic Acid (1) · Hydromorphone (1) · Phenytoin (1) · Secretory Leukocyte Peptidase Inhibitor (1) · Standard of Care (1) · butyl aminobenzoate, eugenol, iodoform, spearmint oil drug combinations (1) · octyl 2-cyanoacrylate (1)
Renovo (4) · Antoni Ribas (1) · BioMendics, LLC (1) · Cairo University (1) · GlaxoSmithKline (1) · Hordinsky, Maria K., MD (1) · Icahn School of Medicine at Mount Sinai (1) · Mansoura University (1) · Massachusetts General Hospital (1) · Nantes University Hospital (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · OcuNexus Therapeutics, Inc. (1) · SB Istanbul Education and Research Hospital (1) · Shahid Beheshti University of Medical Sciences (1) · University Hospital, Basel, Switzerland (1)
United States (9) · United Kingdom (4) · Egypt (2) · France (1) · Iran (1) · New Zealand (1) · Switzerland (1) · Turkey (Türkiye) (1)
Jonathan Duncan (3) · Michael J Davies (3) · Amanda Truong, MD, PhD (1) · Andrew L Blount, MD (1) · Antoni Ribas, M.D., PhD (1) · Daniel Dante Yeh, MD (1) · Erhan Aysan, MD Prof. (1) · Jeremy Bond (1) · Jeremy C Davis, MD (1) · Jesse Lewin, MD (1) · Karen McGuire, PhD (1) · Maria Hordinsky, MD (1) · Oliver Scheufler, MD, PhD (1)